CLSD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clearside Biomedical Inc

Watchlist Manager

Watchlist

Price: 0.41 USD -26.96% Market Closed

Market Cap: $2.1m

	Clearside Biomedical Inc NASDAQ:CLSD	US
	Marvel Discovery Corp XTSX:MARV	CA
E	Entest Group Inc OTC:ETNI	CN
	Elicera Therapeutics AB F:8E8	SE
	Biosyent Inc XTSX:RX	CA
	APAC Realty Ltd SGX:CLN	SG
	Opawica Explorations Inc F:OE5	CA
	Ur-Energy Inc TSX:URE	US
	Giftee Inc TSE:4449	JP

Profitability Summary

Clearside Biomedical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

77%

Negative Operating Margin

-525%

Negative 3Y Average Operating Margin

-822%

Operating Margin is Increasing

-3 084% > -525%

Negative Net Margin

-665%

Negative 3Y Average Net Margin

-1 013%

Net Margin is Increasing

-3 529% > -665%

Negative Free Cash Flow Margin

-534%

Negative 3Y Average Free Cash Flow Margin

-720%

Free Cash Flow Margin is Increasing

-2 534% > -534%

Exceptional ROE

72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1 279%

ROIC is Increasing

-3 022% > -573%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.